<img src="https://secure.deep4jibe.com/186037.png" alt="" style="display:none;">
Arria showcases automated Clinical Safety Reports at the DIA Pharmacovigilance and Risk Management Strategies Conference
January 31, 2020 | Jennifer Mastrangelo

This week we showcased automated Clinical Safety Reports at DIA’s Pharmacovigilance and Risk Management Strategies Conference. At the show we featured the work we are doing with various pharmaceutical companies to expedite and improve their reporting. We have helped these companies with financial reporting as well as with other drug lifecycle-focused use cases.

As you may already know…bringing a drug to market can be a difficult and drawn-out process. Pharmaceutical companies consistently have to report to regulators, governments, and consumers on drug efficacy and safety. They also have to maintain transparency, accountability, and innovation in their drug development process while staying in budget.

It was a no-brainer for us to attend and spread the word about how Arria NLG can relieve some of the burden by automating aspects of these requirements.

“At DIA, it was wonderful to see attendees connect with us and truly understand Arria's ability to significantly improve CSR data set analysis. Many recognized that Arria’s AI technology can drastically reduce manual case report workflows allowing teams to prioritize time in order to derive deeper insights from signal detection, increase overall case intelligence, and expand aggregate report generation capabilities.” –Phillip Edgar, Arria NLG

While at the event we discovered that Arria NLG’s role in working with the Pharmaceutical space does not stop with financial reporting or CSRs. While speaking with Pharmacovigilance Organizations (PV) we identified a way to leverage NLG to mine real world data (RWD) to identify real world evidence (RWE).

This process for many is painstakingly manual, taking up valuable time. Where do they find this data and evidence? Typically, in massive aggregated spreadsheets or dashboards that can only display certain data points in visuals.

PV organizations can experience tremendous value and benefits by adding NLG to existing dashboards to enhance user experience, improve the quality and consistency of narratives, freeing up analysts to perform higher value tasks, while expediting the cycle of bringing safe and effective drugs to market quickly for patients.

We are delighted to be able to continue our journey with the pharmaceutical and healthcare industries to bring life-changing drugs to patients faster.

Are you ready to see how Arria can improve drug efficacy and safety for your patients? Request a demo now!

Keep up with the latest trends — connect with us and register for an upcoming webinar!

The Arria Blog

Subscribe to the Blog

Follow Arria NLG